wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26767182-23C851A2-2879-477A-878B-5051C7FB833F
Q26767182-23C851A2-2879-477A-878B-5051C7FB833F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767182-23C851A2-2879-477A-878B-5051C7FB833F
Molecular targeted therapy to improve radiotherapeutic outcomes for non-small cell lung carcinoma
P2860
Q26767182-23C851A2-2879-477A-878B-5051C7FB833F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767182-23C851A2-2879-477A-878B-5051C7FB833F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b72d1d096de121cfbce3bfb3741deb59cd2d7eed
P2860
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.